OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.490
+0.070 (1.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
OptimizeRx Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 8.80, with a low estimate of 5.00 and a high estimate of 16. The average target predicts an increase of 95.99% from the current stock price of 4.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 1 | 1 | 1 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $16 → $8 | Buy | Maintains | $16 → $8 | +78.17% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $7 | Buy | Maintains | $14 → $7 | +55.90% | Nov 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $16 | Strong Buy | Reiterates | $20 → $16 | +256.35% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +78.17% | Nov 14, 2024 |
| Barclays | Barclays | Hold Maintains $11 → $5 | Hold | Maintains | $11 → $5 | +11.36% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
102.71M
from 71.52M
Increased by 43.61%
Revenue Next Year
115.98M
from 102.71M
Increased by 12.92%
EPS This Year
0.36
from -1.03
EPS Next Year
0.50
from 0.36
Increased by 39.65%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 107.2M | 126.5M | 132.3M |
| Avg | 102.7M | 116.0M | 128.5M |
| Low | 98.0M | 107.8M | 123.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 49.9% | 23.1% | 14.1% |
| Avg | 43.6% | 12.9% | 10.8% |
| Low | 37.0% | 5.0% | 6.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.40 | 0.60 | 0.90 |
| Avg | 0.36 | 0.50 | 0.88 |
| Low | 0.34 | 0.42 | 0.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 65.6% | 78.9% |
| Avg | - | 39.7% | 73.8% |
| Low | - | 16.6% | 67.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.